Tuesday’s Top Analyst Takeaways: Key Coverage Notes on Nvidia, SpaceX, American Airlines, and More

Morgan Stanley maintains its overweight rating for SpaceX. The firm notes the stock is passing through ‘peak neocloud,’ highlighting advantages in intelligence-per-watt-per-dollar-per-second metrics. Heading into 2027, they expect SPCX to undergo a profound shift into robotics, mesh networks, and space-based infrastructure.
Cantor Fitzgerald initiates coverage of Ralph Lauren with an overweight rating, citing strong brand equity and a premier management team with room to expand across all three key geographies. The company is also a share-gain compounding force in inclusive luxury.
Jefferies reiterates a hold rating on Tesla. While the potential SpaceX merger remains unchanged, the recent implementation may be more challenging. Q3 results demonstrated underlying free cash flow strength, which is critical for supporting broader investments across Musk-led businesses.
UBS downgrades Carlyle Group to neutral from buy due to diminishing confidence in the company’s growth profile and path to 2028 financial objectives.
Jefferies initiates Alvotech as a buy, labeling it a turnaround story. The biotech company has established itself as a reliable biosimilar development and manufacturing partner.
JPMorgan upgrades British American Tobacco to overweight from neutral, reinstating coverage. The company’s next-generation product development has yielded significant results, including a step-change in US nicotine pouch share and leadership in European category development.
Jefferies upgrades Riot Platforms to buy from hold, citing substantial upside potential. The bitcoin miner and digital infrastructure company offers considerable further investment room.
Citi upgrades Securitize to buy from neutral. While uncertainties regarding long-term monetization and potential lockup-related share supply dynamics remain, the risk/reward profile has improved meaningfully following the stock’s mid-October pullback.
UBS upgrades Millicom to buy from neutral, raising the price target to $109 from $100 based on increased conviction in underlying operating drivers and their confidence in the free cash flow trajectory.
UBS upgrades Morgan Stanley Direct Lending Fund to buy from neutral following earnings. The price target is lowered to $14.50 from $15.50 after the fund reported a 3.8% quarter-over-quarter NAV decline driven by several challenged credits.
JPMorgan initiates Comfort Systems and Sterling Infrastructure as overweight, describing both companies as infrastructure juggernauts.
Goldman Sachs initiates City Therapeutics as early-stage biotech, highlighting a robust pipeline of RNA interference therapeutics for large-market and rare disease indications.
Citi reiterates its buy rating on Nvidia, lowering the price target to $285 per share from $315 ahead of upcoming earnings. They expect the company to maintain a 70% year-over-year revenue outlook.
Wells Fargo reiterates an overweight rating on Nvidia, lowering the price target to $300 per share from $315 ahead of earnings. They anticipate solid upside in FQ3 2027 and highlight supply-side production capacity scaling and visibility into CY28+ demand as key topics.
Rothschild & Co Redburn upgrades American Airlines to buy from neutral, citing multiple positive catalysts ahead based on improved network and outer-year margin generation potential.
BTIG initiates MongoDB as a buy, offering a $417 price target. They believe several tailwinds can support over 20% revenue growth over the next few years.
Cantor Fitzgerald initiates Tapestry as overweight, emphasizing a product-and-margin story that the market currently views conservatively but holds strong room for earnings growth.

Source link